ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 per shares (the "Shares") (ASMB)

Q: What does CUSIP 045396207 represent in this 13F holders report?

CUSIP 045396207 is the security identifier for ASMB - ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 per shares (the "Shares") used to aggregate holder disclosures.

Q: How many institutions held ASMB - ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 per shares (the "Shares") in Q2 2025?

33 institutional investors reported ASMB - ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 per shares (the "Shares") for Q2 2025. Use the holders table for investor-level position and value details.

CUSIP: 045396207

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Common Stock, par value $0.001 per shares (the "Shares")
Shares outstanding: 15,738,333
Total 13F shares: 3,148,479
Share change: -27,160
Total reported value: $57,049,319
Price per share: $18.12
Number of holders: 33
Value change: +$415,033
Number of buys: 12
Number of sells: 16

Quarterly Holders Quick Answers

What is CUSIP 045396207?
CUSIP 045396207 identifies ASMB - ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 per shares (the "Shares") in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025
Previous quarter: Q1 2025

Recent filing periods for CUSIP 045396207:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ASMB - ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 per shares (the "Shares") (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
GILEAD SCIENCES, INC.	13F	Company	14%	2,209,471	$21,122,543	—	31 Mar 2025	13F
Alexander Schornstein	3/4/5	10%+ Owner	— class O/S missing	728,113	$10,812,478	—	22 Nov 2024	3/4/5
VANGUARD GROUP INC	13F	Company	1.4%	215,983	$2,064,797	—	31 Mar 2025	13F
B Group, Inc.	13F	Company	1.3%	200,000	$1,912,000	—	31 Mar 2025	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.72%	113,311	$1,083,253	—	31 Mar 2025	13F
BlackRock, Inc.	13F	Company	0.5%	78,988	$755,125	—	31 Mar 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.3%	47,703	$456,174	—	31 Mar 2025	13F
MONIMUS CAPITAL MANAGEMENT, LP	13F	Company	0.27%	42,067	$402,161	—	31 Mar 2025	13F
NORTHERN TRUST CORP	13F	Company	0.18%	28,323	$270,768	—	31 Mar 2025	13F
FEDERATED HERMES, INC.	13F	Company	0.16%	25,394	$242,767	—	31 Mar 2025	13F
ARMISTICE CAPITAL, LLC	13F	Company	0.15%	23,858	$228,082	—	31 Mar 2025	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.15%	23,027	$219,000	—	31 Mar 2025	13F
Squarepoint Ops LLC	13F	Company	0.12%	18,982	$181,468	—	31 Mar 2025	13F
John G. McHutchison	3/4/5	Director	— mixed-class rows	21,847 mixed-class rows	$180,683	—	05 Jun 2025	3/4/5
MARSHALL WACE, LLP	13F	Company	0.11%	18,040	$172,462	—	31 Mar 2025	13F
Palumbo Wealth Management LLC	13F	Company	0.11%	17,986	$171,947	—	31 Mar 2025	13F
Man Group plc	13F	Company	0.11%	17,952	$171,621	—	31 Mar 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.11%	17,414	$166,478	—	31 Mar 2025	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.1%	15,225	$145,551	—	31 Mar 2025	13F
STATE STREET CORP	13F	Company	0.09%	14,009	$133,926	—	31 Mar 2025	13F
CITADEL ADVISORS LLC	13F	Company	0.08%	12,258	$117,186	—	31 Mar 2025	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.07%	11,799	$112,798	—	31 Mar 2025	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.06%	10,182	$97,340	—	31 Mar 2025	13F
Michael P. Samar	3/4/5	Chief Financial Officer	— class O/S missing	77,228	$61,782	—	25 Jul 2022	3/4/5
FMR LLC	13F	Company	0.04%	5,659	$54,100	—	31 Mar 2025	13F
Michael Houghton	3/4/5	Director	— mixed-class rows	6,702 mixed-class rows	$49,998	—	05 Jun 2025	3/4/5
BARCLAYS PLC	13F	Company	0.02%	3,431	$32,800	—	31 Mar 2025	13F
Luisa M. Stamm	3/4/5	Chief Medical Officer	— mixed-class rows	152,815 mixed-class rows	$32,252	—	29 Mar 2022	3/4/5
MORGAN STANLEY	13F	Company	0.01%	2,300	$21,988	—	31 Mar 2025	13F
UBS Group AG	13F	Company	0%	767	$7,333	—	31 Mar 2025	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	361	$3,451	—	31 Mar 2025	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	302	$2,887	—	31 Mar 2025	13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	13F	Company	0%	260	$2,486	—	31 Mar 2025	13F
RHUMBLINE ADVISERS	13F	Company	0%	190	$1,816	—	31 Mar 2025	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	145	$1,386	—	31 Mar 2025	13F
AMERIFLEX GROUP, INC.	13F	Company	0%	83	$793	—	31 Mar 2025	13F
SBI Securities Co., Ltd.	13F	Company	0%	67	$641	—	31 Mar 2025	13F
EverSource Wealth Advisors, LLC	13F	Company	0%	55	$526	—	31 Mar 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	39	$373	—	31 Mar 2025	13F
JPMORGAN CHASE & CO	13F	Company	0%	7	$67	—	31 Mar 2025	13F
Frazier Financial Advisors, LLC	13F	Company	0%	1	$10	—	31 Mar 2025	13F
Richard D. DiMarchi	3/4/5	Director	— class O/S missing	20,000	—	—	25 May 2022	3/4/5
Myron Z. Holubiak	3/4/5	Director	— class O/S missing	15,000	—	—	20 May 2021	3/4/5
Anthony E. Altig	3/4/5	Director	— class O/S missing	3,500	—	—	05 Jun 2025	3/4/5
Gina Consylman	3/4/5	Director	— class O/S missing	3,500	—	—	05 Jun 2025	3/4/5
Lisa Johnson-Pratt	3/4/5	Director	— class O/S missing	3,500	—	—	05 Jun 2025	3/4/5
Susan Mahony	3/4/5	Director	— class O/S missing	3,500	—	—	05 Jun 2025	3/4/5
William R. Ringo	3/4/5	Director	— class O/S missing	3,500	—	—	05 Jun 2025	3/4/5

Institutional Holders of ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 per shares (the "Shares") (ASMB) as of Q2 2025

As of 30 Jun 2025, ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 per shares (the "Shares") (ASMB) was held by 33 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,148,479 shares. The largest 10 holders included GILEAD SCIENCES, INC., VANGUARD GROUP INC, B Group, Inc., RENAISSANCE TECHNOLOGIES LLC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, MONIMUS CAPITAL MANAGEMENT, LP, CITADEL ADVISORS LLC, NORTHERN TRUST CORP, and FEDERATED HERMES, INC.. This page lists 33 institutional shareholders reporting positions in this security for the Q2 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

Q2 2025 holders

Holder diff

-3

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 Value $	Q2 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.